Avidity Partners Management LP Catalent, Inc. Transaction History

Avidity Partners Management LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $1.09 Million - $1.7 Million	-15,000 Reduced 1.57%	940,000 $68 Million
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $15.1 Million - $19.7 Million	173,000 Added 22.12%	955,000 $102 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $8.19 Million - $10.8 Million	87,000 Added 12.52%	782,000 $86.7 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $35.5 Million - $41.3 Million	297,000 Added 74.62%	695,000 $89 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $15.5 Million - $20.2 Million	-142,000 Reduced 26.3%	398,000 $53 Million
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $2.01 Million - $2.31 Million	-20,000 Reduced 3.57%	540,000 $58.4 Million
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $22.6 Million - $27.9 Million	223,000 Added 66.17%	560,000 $59 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $1.62 Million - $1.99 Million	18,900 Added 5.94%	337,000 $35.1 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $23.1 Million - $29.4 Million	318,100 New	318,100 $27.2 Million
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $19.7 Million - $32.5 Million	-411,000 Closed	0 $0
Q1 2020 Jun 17, 2020	BUY	$36.95 - $62.95 $15.2 Million - $25.9 Million	411,000 New	411,000 $21.4 Million
Q1 2020 May 15, 2020	SELL	$36.95 - $62.95 $3.4 Million - $5.79 Million	-92,000 Closed	0 $0
Q4 2019 Jun 17, 2020	BUY	$47.06 - $56.64 $4.33 Million - $5.21 Million	92,000 New	92,000 $5.18 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.